[1]
Sadeghi, S. and Goodarzi, A. 2022. Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective. Dermatology Practical & Conceptual. 12, 4 (Oct. 2022), e2022178. DOI:https://doi.org/10.5826/dpc.1204a178.